Sökresultat

Filtyp

Din sökning på "*" gav 563751 sökträffar

How your lifestyle can affect your risk of dementia

Almost half of all dementia cases can be attributed to risk factors that we potentially can influence ourselves, such as smoking and high blood pressure. A new study from Lund University shows which risk factors are associated with two of our most common causes of dementia – Alzheimer's disease and vascular dementia. During our lifetime, the risk of developing dementia is influenced by aspects tha

https://www.lunduniversity.lu.se/article/how-your-lifestyle-can-affect-your-risk-dementia - 2026-08-07

Health benefits if cities are densified in the right way

It is not easy to be an urban planner. Cities must be built more densely because surrounding agricultural land and nature must be protected – while at the same time health requirements are high. Over a period of five years researchers at Lund University in Sweden, have closely studied densification plans in three cities and found keys to solving this difficult equation. In short, the solution is t

https://www.lunduniversity.lu.se/article/health-benefits-if-cities-are-densified-right-way - 2026-08-07

Lund University ranked number one in the Nordic region

Lund University is strengthening its position as one of Europe's leading universities and ranks the highest among the Nordic universities in the QS World University Rankings: Europe 2026. ”At Lund University we conduct research and education that truly makes a difference. That we are now ranked as the leading university in the Nordic region and as number one in the world for sustainability, is bot

https://www.lunduniversity.lu.se/article/lund-university-ranked-number-one-nordic-region - 2026-08-07

Caesarean sections for sale

In a recently published review article from Lund University researchers have analysed the incidence of caesarean sections in different European countries. The results show that private hospitals in several countries have a higher proportion of caesarean sections than public hospitals, even among women in low-risk groups. The caesarean section rate varied from around 17 per cent in northern Europe

https://www.lunduniversity.lu.se/article/caesarean-sections-sale - 2026-08-07

Unprecedented interest in Lund University’s international recruitment

There has been a record-breaking number of applicants for Lund University’s international recruitment drive. The original total of 25 advertised positions has been increased to 45 – researchers from some of the world’s leading universities who are now heading to Lund. The recruited researchers come from higher education institutions such as Harvard University, the University of Oxford, the Humbold

https://www.lunduniversity.lu.se/article/unprecedented-interest-lund-universitys-international-recruitment - 2026-08-07

Lund Stem Cell Center joins BEYOND European postdoctoral programme in advanced therapies

The Lund Stem Cell Center at Lund University is a partner in BEYOND, a new European postdoctoral training programme designed to prepare the next generation of researchers in advanced cell and gene therapies. Coordinated by Fondazione Telethon, the programme is supported by €6 million from the Horizon Europe Marie Skłodowska Curie Actions (MSCA) COFUND scheme and will fund 35 international postdoct

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-beyond-european-postdoctoral-programme-advanced-therapies - 2026-08-07

STEM-PD enters a new chapter as Cellular Intelligence acquires global rights to advance the stem cell therapy for Parkinson's Disease

The STEM PD clinical trial, a stem cell–based approach for Parkinson’s disease, is entering a new phase in its development. In May 2026, Cellular Intelligence, an AI native biotech company, announced that it has acquired global rights from the Danish pharmaceutical company, Novo Nordisk, to further advance the clinical development of the STEM PD programme. STEM‑PD is among a small number of plurip

https://www.stemcellcenter.lu.se/article/stem-pd-enters-new-chapter-cellular-intelligence-acquires-global-rights-advance-stem-cell-therapy - 2026-08-07

A training ground for cell and gene therapies: New pre-GMP facility aims to smooth the path from idea to patient

When research findings are ready to make the leap from the lab to the patient, the requirements become much stricter. That is precisely where many promising projects start to falter. “We want to be the bridge between research and the patient, so that promising projects don’t get stuck in that difficult transition,” says Sara Nolbrant, director of the new pre-GMP facility. And with that, she disapp

https://www.stemcellcenter.lu.se/article/training-ground-cell-and-gene-therapies-new-pre-gmp-facility-aims-smooth-path-idea-patient - 2026-08-07

Lund Stem Cell Center welcomes four new research group leaders

Lund Stem Cell Center continues to grow as a leading hub for interdisciplinary stem cell research, welcoming four new principal investigators into its research community. Together, they bring specialised expertise spanning molecular and cell biology, immunology and bioengineering, further strengthening the Center’s scientific scope and possibilities for collaboration. How cells protect their DNA,

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-welcomes-four-new-research-group-leaders - 2026-08-07

STEM-PD announces first in-human clinical trial results for Parkinson’s disease cell therapy

A landmark study led from Lund, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow up. The results are published in Nature Medicine. In Parkinson’s disease, patients lose nerve cells in

https://www.stemcellcenter.lu.se/article/stem-pd-announces-first-human-clinical-trial-results-parkinsons-disease-cell-therapy - 2026-08-07

Welcome two new Principal Investigators to Lund Stem Cell Center

This article is over 5 years old, and the information may therefore be outdated. Principal Investigators Daniella Ottosson and Charlotta Böiers have been accepted to join Lund Stem Cell Center.A warm welcome to the Ottosson and Böiers groups. To learn more about their research, the following Stem Cell Talks have been scheduled: Wednesday 25th September: Principal Investigator Daniella Ottosson. De

https://www.stemcellcenter.lu.se/article/welcome-two-new-principal-investigators-lund-stem-cell-center - 2026-08-07

Tailored therapy for chronic myeloid leukaemia

This article is over 5 years old, and the information may therefore be outdated. Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the pat

https://www.stemcellcenter.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2026-08-07

Cancerfonden supports research into the role of RNA modification in cancer development

This article is over 5 years old, and the information may therefore be outdated. The Swedish Cancer Foundation, Cancerfonden, has announced the researchers it will be supporting in its most recent round of funding and Lund Stem Cell Center was especially successful, with seven scientists awarded a total of almost 30 million SEK. Cristian Bellodi, a research team leader from the Division of Molecul

https://www.stemcellcenter.lu.se/article/cancerfonden-supports-research-role-rna-modification-cancer-development - 2026-08-07

Filipe Pereira awarded European Research Council Consolidator Grant

This article is over 5 years old, and the information may therefore be outdated. Today the European Research Council (ERC) announced the winners of its latest Consolidator Grant competition and Filipe Pereira, group leader in the Department of Laboratory Medicine, was one of the researchers awarded this highly competitive grant. One of 89 researchers selected from a total of 707 applicants in the

https://www.stemcellcenter.lu.se/article/filipe-pereira-awarded-european-research-council-consolidator-grant-0 - 2026-08-07

How self-reactive immune cells are allowed to develop

This article is over 5 years old, and the information may therefore be outdated. Directly after birth, the immune system completes production of a subtype of antibody-producing immune cells, B-1, that are to last for a lifetime. No more B1-cells are formed after that point. However, these cells are self-reactive – they produce not only antibodies against foreign substances, but also against the bo

https://www.stemcellcenter.lu.se/article/how-self-reactive-immune-cells-are-allowed-develop - 2026-08-07

How do dementia diseases affect our brains?

This article is over 5 years old, and the information may therefore be outdated. By Pia [dot] romare [at] fsi [dot] lu [dot] se (Pia Romare) - published on 23 August 2018“We must understand the ageing process itself in order to help people with conditions such as Alzheimer’s and dementia, and to possibly enable us to prevent these diseases from arising”, says Henrik Ahlenius of the Stem Cell Centr

https://www.stemcellcenter.lu.se/article/how-do-dementia-diseases-affect-our-brains - 2026-08-07

Prestigious scientific prize awarded to Director of Lund Stem Cell Center

This article is over 5 years old, and the information may therefore be outdated. Zaal Kokaia, Professor within the Department of Clinical Sciences and Director of Lund Stem Cell Center, has been awarded Georgia’s most prestigious scientific prize - the National Prize in Science.  The award comes as a result of his outstanding contribution to world class scientific research and was presented to Pro

https://www.stemcellcenter.lu.se/article/prestigious-scientific-prize-awarded-director-lund-stem-cell-center - 2026-08-07

Thesis Defence Interview - Margarita Chumarina

This article is over 5 years old, and the information may therefore be outdated. Margarita Chumarina, from the iPSC laboratory for CNS disease modeling, will be defending her PhD thesis on Wednesday 15th of January. Researching in the group led by Laurent Roybon, Margarita has been utilizing stem cell-based models to study cellular alterations in Parkinson’s disease. Here, Margarita answers a few

https://www.stemcellcenter.lu.se/article/thesis-defence-interview-margarita-chumarina - 2026-08-07

Thesis Defence Interview - Sara Nolbrant

This article is over 5 years old, and the information may therefore be outdated. Sara Nolbrant, from the Developmental and Regenerative Neurobiology lab, will be defending her PhD thesis on Friday 31st of January. Researching in the group led by Malin Parmar, Sara has been directing and dissecting the fate of dopaminergic neurons with the aim developing cell replacement therapy for the treatment o

https://www.stemcellcenter.lu.se/article/thesis-defence-interview-sara-nolbrant - 2026-08-07